Small Cap Confidential Logo

If you're looking the next up-and-coming stocks then look no further than Cabot Small-Cap Confidential. We limit the circulation of our advisory so that our subscribers own the stocks before the big institutions start buying them.

Each month Chief Analyst Thomas Garrity will present a new small-cap stock with his in-depth research. You'll see many stocks from emerging technologies, including mobile telecommunications, biotech, cyber security, genetic medicine, bio-pharmaceuticals, sensors, robotics and other fields with unlimited upside potential.

Thomas E. Garrity, Chief Analyst | Read Profile >

Sign up now for a risk-free trial subscription to Cabot Small-Cap Confidential.
If you don’t like it, you'll receive a pro-rated refund.

Why Is Cabot Small-Cap Confidential Right For You?

  • Get some of the best small-cap stocks complete with timely investment advise right to your inbox.
  • Uncover some of the market’s best kept secrets and own them before the big institutions find them.
  • We’ll tell you exactly what action to take at every step of the investment process.
  • Cabot Small-Cap Confidential will introduce you to new, under-reserached companies that could change the world with their products.
  • Own these stocks before they breakout and become household names.
  • Past winners include Questcor Pharmaceuticals +424%, QuickLogic Corporation +286%, Reed's Inc. 250%, UniPixel Inc. 236%
  • Add Tom’s 30 years of investing experience to your portfolio to uncover the most exciting small-cap opportunities.
  • You’re never alone—Chief Analyst Tom Garrity is just an email away.
  • Our 45 years of investing experience puts you in good hands.

These Returns Could Be Yours:

Cabot Small-Cap Confidential: Average return of all stocks since inception (excluding current holdings)

Cabot Small-Cap Confidential Performance

Cabot Small-Cap Confidential's focus is on finding undervalued and little-known small-cap companies with big ideas that serve very large markets. The advisory recommends one stock each month, and usually holds them as long-term investments. The advisory does not present a model portfolio—i.e., there's no cash position, weightings, etc.; however, all recommendations are followed up weekly with buy, hold and eventually sell ratings.The performance shown is the average gain of Cabot Small-Cap Confidential stocks since inception on 10/8/07, excluding current holdings as of 6/29/15.

235% in Baxano Surgical

baxano

187% in Ovascience

ovascience

148% in Cardiovascular Systems

csii

116% in Cerus

cerus

#1 Advantage

Navgiate the fast-paced world of small-cap stocks with Cabot Small-Cap Confidential.  This limited-circulation advisory will help you find the technologies of tomorrow, with virtually limitless profit opportunities. 
Sign up now for a risk-free trial subscription to Cabot Small-Cap Confidential.
If you don’t like it, you'll receive a pro-rated refund.

What our Customers say about Small-Cap Confidential

Tom, I just read your Game Changers report. I've been waiting for a new start-up company dealing with 3-D printing. The future is bright. I'm 73, so my investment time is limited, but I introduced my son to your advisory—he's a finance major so I know his investment future is promising. Keep up the good work. B. Gonzalez, Palos Heights, Illinois

"Tom, looks like your prediction of CSII hitting 40 came true (I think it was about 34 when we exchanged emails). Great long-term pick. Thank you. I have been in since the beginning. Now light a fire under MITK. Appreciate all your great work.”

P. Rosenberg, Bethany Beach, Delaware 
A well researched, easy to read and honestly "marketed" newsletter that has pumped up my portfolio. I have been a Cabot subscriber for several years, a Small-Cap subscriber for a few months, and spent the "big bucks" because of my confidence in the integrity of the Cabot organization. My trust is not easily bestowed...Cabot has worked hard to earn that trust. F. Odon, Olmsted Falls, Ohio

Are you ready to get started with your risk-free trial subscription?

Order Small-Cap Confidential Now

Choose Your Subscription

All prices are introductory offers for new subscribers only. If you are an existing or past subscriber please call us at (800) 326-8826 or email at sales@cabot.net.

Subscriber Information

Payment Information

We accept Visa, MasterCard, Discover, American Express

Order Confirmation

Your Transaction is Secure


All Transactions are Cybersource Secured
Cabot Heritage Corporation BBB Business Review
SSL

You can also place your order by

Calling (800) 326-8826

Faxing your order to 978-745-1283

Mailing a printed form to:
Cabot Heritage Corporation
176 North Street
Salem MA 01970

or you can request more information...

Fill out the form to the right to receive additional information about Small-Cap Confidential, and one of our sales representatives will contact you to answer any additional questions.

Guide to Small-Cap Investing

Guide to Small-Cap Investing

In this guide to Cabot Small-Cap Confidential, Chief Analyst Tom Garrity will show you how you can become a smarter, savvier, and wealthier investor in small-cap stocks.  Tom shares with you his 10 Rules for Successful Small-Cap Investing while instructing you on every step of the investment journey.  If you're looking for undiscovered companies with a big idea then you're going to want to take a closer look at Cabot Small-Cap Confidential.